IS6508A - Lyfjasamsetningar af glycogen fosfórýlasa lötum - Google Patents
Lyfjasamsetningar af glycogen fosfórýlasa lötumInfo
- Publication number
- IS6508A IS6508A IS6508A IS6508A IS6508A IS 6508 A IS6508 A IS 6508A IS 6508 A IS6508 A IS 6508A IS 6508 A IS6508 A IS 6508A IS 6508 A IS6508 A IS 6508A
- Authority
- IS
- Iceland
- Prior art keywords
- pharmaceutical formulations
- glycogen phosphorylase
- phosphorylase inhibitors
- inhibitors
- glycogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18994200P | 2000-03-16 | 2000-03-16 | |
| PCT/IB2001/000394 WO2001068055A1 (en) | 2000-03-16 | 2001-03-16 | Pharmaceutical compositions of glycogen phosphorylase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6508A true IS6508A (is) | 2002-08-16 |
Family
ID=22699402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6508A IS6508A (is) | 2000-03-16 | 2002-08-16 | Lyfjasamsetningar af glycogen fosfórýlasa lötum |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20010053778A1 (is) |
| EP (1) | EP1263414A1 (is) |
| JP (1) | JP2003526654A (is) |
| KR (1) | KR20020081445A (is) |
| CN (1) | CN1418089A (is) |
| AP (1) | AP2002002621A0 (is) |
| AR (1) | AR027656A1 (is) |
| AU (1) | AU2001242669A1 (is) |
| BG (1) | BG107037A (is) |
| BR (1) | BR0109189A (is) |
| CA (1) | CA2403241A1 (is) |
| CO (1) | CO5280087A1 (is) |
| CZ (1) | CZ20022955A3 (is) |
| EA (1) | EA200200858A1 (is) |
| EE (1) | EE200200530A (is) |
| HU (1) | HUP0204583A2 (is) |
| IL (1) | IL151320A0 (is) |
| IS (1) | IS6508A (is) |
| MA (1) | MA26882A1 (is) |
| MX (1) | MXPA02009097A (is) |
| NO (1) | NO20024386L (is) |
| OA (1) | OA12232A (is) |
| PA (1) | PA8513601A1 (is) |
| PE (1) | PE20011184A1 (is) |
| PL (1) | PL360780A1 (is) |
| SK (1) | SK12622002A3 (is) |
| SV (1) | SV2002000343A (is) |
| TN (1) | TNSN01040A1 (is) |
| TR (1) | TR200202184T2 (is) |
| WO (1) | WO2001068055A1 (is) |
| YU (1) | YU67202A (is) |
| ZA (1) | ZA200207290B (is) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA006402B1 (ru) * | 1999-12-23 | 2005-12-29 | Пфайзер Продактс Инк. | Комбинация лекарства и целлюлозного полимера, повышающего концентрацию; способ введения лекарства и водный раствор (варианты) |
| CO5271699A1 (es) | 2000-01-24 | 2003-04-30 | Pfizer Prod Inc | Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa |
| WO2003000238A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| CA2450748A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| EP1404300B1 (en) * | 2001-06-22 | 2009-09-30 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| IL162819A0 (en) | 2002-02-01 | 2005-11-20 | Pfizer Prod Inc | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| MXPA04007438A (es) | 2002-02-01 | 2004-10-11 | Pfizer Prod Inc | Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas. |
| JP2005523260A (ja) | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 圧力ノズルを用いた均質噴霧乾燥固体非晶質薬剤分散体の製造方法 |
| GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| US7405210B2 (en) | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| WO2005011635A2 (en) * | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
| US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
| JP2007517016A (ja) * | 2003-12-31 | 2007-06-28 | ファイザー・プロダクツ・インク | 低溶解性薬剤及びポロキサマーの固体組成物 |
| DE602005023965D1 (de) | 2004-03-08 | 2010-11-18 | Prosidion Ltd | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase |
| WO2006059163A1 (en) * | 2004-12-02 | 2006-06-08 | Prosidion Limited | Treatment of diabetes with glycogen phosphorylase inhibitors |
| DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
| JP6224712B2 (ja) | 2012-08-24 | 2017-11-01 | ダウ グローバル テクノロジーズ エルエルシー | 高分子量および均一性の新規エステル化セルロースエーテル |
| UA117353C2 (uk) | 2012-09-11 | 2018-07-25 | Медівейшн Простейт Терап'Ютікс Ллс | Форми дозування ензалутаміду |
| EP3021836B1 (en) * | 2013-07-19 | 2020-10-07 | Siga Technologies Inc. | Amorphous tecovirimat preparation |
| CN103709171B (zh) * | 2014-01-20 | 2015-09-16 | 武汉大学 | 具有哒嗪并[3,4-b]吲哚骨架结构的衍生物及其合成方法 |
| CA2987867C (en) | 2015-06-09 | 2023-06-27 | Capsugel Belgium Nv | Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules |
| CN112442022B (zh) * | 2019-09-02 | 2022-05-20 | 承德医学院 | 苯并嗪-4-酮类化合物、其制备方法及医药用途 |
| US11291701B1 (en) * | 2021-02-04 | 2022-04-05 | Seed Edibles | Orally disintegrating, sublingual and buccal formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6297269B1 (en) * | 1995-06-06 | 2001-10-02 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| ATE206702T1 (de) * | 1995-06-06 | 2001-10-15 | Pfizer | Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren |
| DE69837903T2 (de) * | 1997-08-11 | 2008-02-14 | Pfizer Products Inc., Groton | Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit |
| US5998463A (en) * | 1998-02-27 | 1999-12-07 | Pfizer Inc | Glycogen phosphorylase inhibitors |
-
2001
- 2001-03-14 US US09/805,828 patent/US20010053778A1/en not_active Abandoned
- 2001-03-14 PE PE2001000246A patent/PE20011184A1/es not_active Application Discontinuation
- 2001-03-14 AR ARP010101185A patent/AR027656A1/es not_active Application Discontinuation
- 2001-03-15 TN TNTNSN01040A patent/TNSN01040A1/fr unknown
- 2001-03-15 SV SV2001000343A patent/SV2002000343A/es not_active Application Discontinuation
- 2001-03-16 WO PCT/IB2001/000394 patent/WO2001068055A1/en not_active Application Discontinuation
- 2001-03-16 EP EP01915586A patent/EP1263414A1/en not_active Withdrawn
- 2001-03-16 MX MXPA02009097A patent/MXPA02009097A/es unknown
- 2001-03-16 AU AU2001242669A patent/AU2001242669A1/en not_active Abandoned
- 2001-03-16 CN CN01806619A patent/CN1418089A/zh active Pending
- 2001-03-16 PA PA20018513601A patent/PA8513601A1/es unknown
- 2001-03-16 PL PL36078001A patent/PL360780A1/xx not_active Application Discontinuation
- 2001-03-16 BR BR0109189-1A patent/BR0109189A/pt not_active Application Discontinuation
- 2001-03-16 EE EEP200200530A patent/EE200200530A/xx unknown
- 2001-03-16 YU YU67202A patent/YU67202A/sh unknown
- 2001-03-16 CA CA002403241A patent/CA2403241A1/en not_active Abandoned
- 2001-03-16 HU HU0204583A patent/HUP0204583A2/hu unknown
- 2001-03-16 AP APAP/P/2002/002621A patent/AP2002002621A0/en unknown
- 2001-03-16 IL IL15132001A patent/IL151320A0/xx unknown
- 2001-03-16 TR TR2002/02184T patent/TR200202184T2/xx unknown
- 2001-03-16 CZ CZ20022955A patent/CZ20022955A3/cs unknown
- 2001-03-16 CO CO01021769A patent/CO5280087A1/es not_active Application Discontinuation
- 2001-03-16 EA EA200200858A patent/EA200200858A1/ru unknown
- 2001-03-16 SK SK1262-2002A patent/SK12622002A3/sk unknown
- 2001-03-16 JP JP2001566619A patent/JP2003526654A/ja active Pending
- 2001-03-16 OA OA1200200290A patent/OA12232A/en unknown
- 2001-03-16 KR KR1020027012009A patent/KR20020081445A/ko not_active Application Discontinuation
-
2002
- 2002-08-16 IS IS6508A patent/IS6508A/is unknown
- 2002-08-26 BG BG107037A patent/BG107037A/bg unknown
- 2002-09-11 ZA ZA200207290A patent/ZA200207290B/xx unknown
- 2002-09-11 MA MA26810A patent/MA26882A1/fr unknown
- 2002-09-13 NO NO20024386A patent/NO20024386L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN01040A1 (fr) | 2005-11-10 |
| SV2002000343A (es) | 2002-07-03 |
| NO20024386D0 (no) | 2002-09-13 |
| SK12622002A3 (sk) | 2004-02-03 |
| JP2003526654A (ja) | 2003-09-09 |
| PL360780A1 (en) | 2004-09-20 |
| CA2403241A1 (en) | 2001-09-20 |
| BG107037A (bg) | 2003-04-30 |
| KR20020081445A (ko) | 2002-10-26 |
| IL151320A0 (en) | 2003-04-10 |
| PA8513601A1 (es) | 2004-08-31 |
| AR027656A1 (es) | 2003-04-09 |
| EA200200858A1 (ru) | 2003-02-27 |
| ZA200207290B (en) | 2003-09-11 |
| AP2002002621A0 (en) | 2002-09-30 |
| AU2001242669A1 (en) | 2001-09-24 |
| PE20011184A1 (es) | 2001-11-15 |
| OA12232A (en) | 2006-05-10 |
| EE200200530A (et) | 2004-04-15 |
| MA26882A1 (fr) | 2004-12-20 |
| YU67202A (sh) | 2006-01-16 |
| CO5280087A1 (es) | 2003-05-30 |
| US20010053778A1 (en) | 2001-12-20 |
| CZ20022955A3 (cs) | 2003-09-17 |
| CN1418089A (zh) | 2003-05-14 |
| TR200202184T2 (tr) | 2003-01-21 |
| MXPA02009097A (es) | 2003-03-12 |
| WO2001068055A1 (en) | 2001-09-20 |
| EP1263414A1 (en) | 2002-12-11 |
| HUP0204583A2 (hu) | 2003-04-28 |
| NO20024386L (no) | 2002-11-13 |
| BR0109189A (pt) | 2003-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6508A (is) | Lyfjasamsetningar af glycogen fosfórýlasa lötum | |
| FI20105657A (fi) | Farmaseuttisia koostumuksia | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| NO20024175L (no) | Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene | |
| NO20033556L (no) | Farmasöytiske formuleringer | |
| CY2013011I1 (el) | Μεθοδος χορηγησης διφωσφονικων | |
| DK1309327T3 (da) | Farmaceutiske sammensætninger af østrogene midler | |
| ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
| FI20011478A0 (fi) | Farmaseuttinen koostumus | |
| DK1417180T3 (da) | Fremstilling af aminopyrimidinforbindelser | |
| NO20040125L (no) | Enterale formuleringer | |
| ID30590A (id) | Celana sekali pakai jenis-celana pendek | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| IS7051A (is) | Lyfjasamsetningar | |
| AR028281A1 (es) | Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona | |
| FI20022128A (fi) | Farmaseuttinen koostumus | |
| DK1331935T3 (da) | Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf | |
| PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
| NO20030156D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
| EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
| ITMI20000554A0 (it) | Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono | |
| PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
| EE200300161A (et) | Triasooliderivaadid ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE200300465A (et) | Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid |